FOR HEALTHCARE
ViewMind Atlas™ captures eye-movement responses during validated cognitive tasks to deliver objective data for evaluation, monitoring, and longitudinal care.
ViewMind Atlas captures both the physiological signal and the behavioral response during validated cognitive tasks, producing structured data across multiple cognitive domains. It is sensitive to functional alterations that may precede observable symptoms, enabling earlier identification and more precise patient stratification.
Proprietary algorithms analyze these signals at high temporal resolution, generating data that complements existing clinical evaluation and supports longitudinal patient monitoring.
ViewMind Atlas provides objective, quantifiable data to complement existing clinical evaluation. It captures the functional dynamics that biomarkers and imaging alone do not reveal: how the brain performs under cognitive demand, in real time.
Sensitive to physiological patterns associated with early-stage conditions, including when standard assessments remain within normal ranges.
Objective, reproducible data alongside structural imaging and fluid biomarkers.
Longitudinal tracking with the sensitivity needed for meaningful within-subject comparisons.
A 15-minute, non-invasive assessment that requires no physician time during administration.
Available instantly on the ViewMind Portal, structured to support clinical interpretation rather than replace it.
With demonstrated correlations to volumetric MRI, amyloid and tau PET imaging, and inflammatory biomarkers including GFAP, YKL-40, p-tau 217, Aβ40 and Aβ42.
ViewMind's validation spans:
Published results show sensitivity to preclinical pathology, strong concordance with established clinical measures. Diagnostic accuracy up to AUC 0.88. Test-retest reliability is classified as Excellent (W ≈ 0.9).
ViewMind Atlas is included in BioHermes-002, validating novel biomarkers in patients at risk of or diagnosed with Alzheimer's disease.
1,000 patients across 32 clinical sites.
For Preventive Health
For Healthcare
For Research
